Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is amazing that this isn't trading between $1 and $2 waiting on big IB/BP coming in..for what they're attacking and size of the markets...
Picked up 20k .555
Wow I guess they needed 100%
It hasn't affected share price because this is so undervalued...now we're at 92% mono with NO toxicity and bringing on one of the top docs on this planet for cancer and we're still sitting at .56...I'm buying more today
Everyone talking about the prostagene deal..it's done it's going to happen... we're over 90% in mono and still at .56 which is a joke....only thing that matters is financing if that is strong we go to $3
He thinks he's a superstar in the biotech world...he's a joke
That Adam Feuerstien is a scam....really don't get why people listen to him...he's clueless
Don't need that Adam Feuerstien guy...need big IB behind us and then we're in a different ballgame...
So we wouldn't want $4b.... $10 a share
Sell it to Gilead's competition and let's move on...
Stock rips bc the science is amazing and if they try to go forward and go it alone the stock will drop big time.,love how we talk about long long long term huge rev but the reality is sell the company bc many things can go wrong and BP can deal with that cydy can't....I'm not being negative, I'm so positive but I'm trying to be real...this company will never do 5b in rev....leave that for bp,..
So 11m less in the float...so Pestell only costing us 16m shares
And BTW that is what's going to happen. They move mono down the road and getting these phase 2 trials for cancer and the stock will be trading at $4 to $5, they'll get that offer of $8 to $10 a share
A trader is looking at .50 and flipping at .75 or $1...that is not me but taking this to a $30b valuation is not an easy task....who here seriously wouldn't take $3 to $4b in the next 6 months...
I do know the value that's why I'm in big.....I just don't feel nadar has experience and can turn this into a big revenue company and we will need serious money behind us and so far it hasn't happened....if that changes I'll feel different but $2.5b to $4b is nothing to sneeze at...
You're saying that to me that I don't recognize the value??? I do recognize the value that's why I have a ton of shares... But I guess the rest of the world doesn't....
Totally agree...go after Gilead's competition
I do think when this hits the market it will ramp up faster bc we'd have no competition and word would spread in the HIV world. But, I still say sell it and move on and $2.5b to $4b sounds great to me.
Stock will easily be $2 by then...when this happens we can start talking about BO...hard to even imagine BO thoughts when we're trading in the .50's
When do the 60m warrants expire?
Than you should be all in if you would be upset with $5 with this trading at .57...can't be a pig and it's ok to leave some on the table
Because I don't feel we can do it alone and it's nice to talk about 500m a billion in rev we have 5 employees and not sure I trust nadar to turn this into a revenue company.... unless a major deal done with a big IB and get serious money behind us then I'd sell it at a discount sooner...you're telling me you wouldn't jump all over $5
I think it could easily happen...$5 the board would jump all over it and Dr P's would also
Gilead is not the only player and what happens to Gilead if someone else buys them...Gilead would be in serious trouble...cydy will be gone in the next 6 months and my guess is $5
100% agree...need big IB behind us and it goes to $4...to much potential this far along in big markets to be under a billion mcap
I was in France and was in a plane...is that a issue
Did they have a call today..I've been traveling
170m mcap...crazy
To me it's all about the higher dose for mono that will bring BP/IB behind us and will give us the valuation we deserve..
What amazing is this is trading at .50 and not $5...this will fly soon
I think by the end of 2018 this will be dramatically different company.
If not sold they would have a billion MCAP...
They'll lose half their HIV revenues if they don't deal with us...
The market doesn't understand how valuable pro 140 is....as soon as big IB or BP jumps in it's a new game...cydy been very silent and should hear mono update on 700 soon....
Wow 225m MCAP...what a buy
Amrn had great news about a month ago in phase 3. Their drug is going after a $3 to $4b market and stock went from $2.50 to $22 with a $6.5b MCAP. So cydy has strong mono results just off that without cancer cydy has the potential of going to $20. I think big IB/BP or both will jump in as soon as we get the numbers from the 700 dose and if in that 90% it's a no brainier. Am I thinking wrong here?
The question is if they get 90% mono and drug gets approval how much is cydy worth?
Forget cancer for now.
I also believe Pestell is joining us bc he's seeing what's going on with mono and it confirms what he's been doing in cancer...drug is amazing and I see a major breakout....something will trigger this and what the market does won't matter....Pestell is telling us this will rip just a matter of time
You have no idea what you're talking about...everyone saying closing that deal is the most important ..not...getting 90% in mono with higher dose and getting major BP or IB deal is what will take us to the promise Land. Pestell closing just tells us more clarity that our drug is amazing which we know..90% mono and pivotal trial will take us to billion mcap
I believe we're on the 1 yard line and about to call a QB sneak